Full history for every metric is available with a Kvantra account
Semler Scientific, Inc. (SMLR)
Key financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 33 | 39 | 53 | 57 | 68 | 56 | 37 |
| Operating profit | $m | 21 | -35 | |||||
| Net profit | $m | 15 | 14 | 17 | 14 | 21 | 41 | 48 |
| EPS reported | $ | 5.13 | 2.78 | |||||
| Operating cashflow per share | $ | 3.38 | -2.31 | |||||
| Capex per share | $ | 26.25 | 16.20 | |||||
| FCF per share | $ | -22.87 | -18.51 | |||||
| Free cash flow | $m | -165 | -389 | |||||
| Net debt | $m | -15 | 106 | |||||
| Book value equity | $m | 231 | 460 | |||||
| Book value per share | $ | 28.92 | 27.79 | |||||
| Number of shares | m | 7.98 | 16.55 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 10.53 | 7.31 | |||||
| P/B LTM | x | 1.69 | 0.68 | |||||
| P/S LTM | x | 6.93 | 8.41 | |||||
| P/FCF LTM | x | -2.36 | -0.80 | |||||
| EV/EBITDA LTM | x | 7.87 | 6.30 | |||||
| EV/Sales LTM | x | 6.78 | 11.28 | |||||
| Earnings Yield LTM | % | 9.50% | 13.68% | |||||
| FCF Yield | % | -42.36% | -125.10% | |||||
| Quality | ||||||||
| ROE | % | 17.72% | 5.71% | |||||
| ROIC | % | 7.65% | -4.24% | |||||
| Operating margin | % | 37.19% | -157.05% | |||||
| Gross margin | % | 91.55% | 90.58% | |||||
| FCF/Sales | % | -293.71% | -1120.1% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +95.06% | +35.52% | |||||
| Sales Growth YoY | % | -17.44% | -37.29% | |||||
| Net Income Growth YoY | % | +98.70% | +203.75% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | -5.94% | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -2,362.01 | -3.34 | |||||
| Net Debt/EBITDA | x | -0.18 | 3.17 | |||||
| EBIT/Net interest | x | 0.00 | -10.52 | |||||
| Net debt/market cap | % | -3.82% | 34.19% | |||||
| Net debt/Equity | x | -0.06 | 0.23 | |||||
| Gross debt/equity | x | 0.00 | 0.25 | |||||
Company overview
Semler Scientific, Inc. develops and delivers cutting-edge technology solutions aimed at boosting the clinical effectiveness and operational efficiency of medical professionals throughout the United States. A flagship offering from the company is QuantaFlo, a rapid, four-minute diagnostic test performed in-office to assess blood flow. This tool allows healthcare providers to incorporate crucial blood flow measurements into their comprehensive evaluations of a patient's vascular health. Their clientele is diverse, spanning various medical specialties such as cardiology, internal medicine, nephrology, endocrinology, podiatry, and family practice. Beyond individual practitioners, Semler Scientific also serves significant healthcare organizations, including insurance plans, integrated care delivery networks, independent physician groups, and other entities that engage with the healthcare sector, such as risk assessment firms. The company distributes its products via a combination of its own sales team and a network of authorized distributors. Founded in 2007, Semler Scientific, Inc. is based in Santa Clara, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Semler Scientific, Inc. (SMLR)
Semler Scientific, Inc. develops and delivers cutting-edge technology solutions aimed at boosting the clinical effectiveness and operational efficiency of medical professionals throughout the United States. A flagship offering from the company is QuantaFlo, a rapid, four-minute diagnostic test performed in-office to assess blood flow. This tool allows healthcare providers to incorporate crucial blood flow measurements into their comprehensive evaluations of a patient's vascular health. Their clientele is diverse, spanning various medical specialties such as cardiology, internal medicine, nephrology, endocrinology, podiatry, and family practice. Beyond individual practitioners, Semler Scientific also serves significant healthcare organizations, including insurance plans, integrated care delivery networks, independent physician groups, and other entities that engage with the healthcare sector, such as risk assessment firms. The company distributes its products via a combination of its own sales team and a network of authorized distributors. Founded in 2007, Semler Scientific, Inc. is based in Santa Clara, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free